Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Doctor

Hepatology · China · 2024-06-05

Processing Time
49 days
Decision Date
2024-06-05
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in hepatology, specifically focusing on improving treatment strategies for acute and chronic liver failure through mRNA nanoparticles for targeted drug delivery and macrophage-targeted therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's work in liver failure treatment and drug delivery platforms addresses a significant national and global health burden.

2 Well-positioned to Advance the Endeavor Met

His Ph.D., extensive publication record, and 42 peer-review assignments demonstrate he is well-positioned to lead this research.

3 Balance of Interests Met

The clinical importance of his liver regeneration research makes it beneficial to the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petitioner demonstrated a strong research record with 16 peer-reviewed articles and 388 citations. His expertise was further validated by 42 peer-review assignments, funding from the National Natural Science Foundation of China, and four expert letters of recommendation confirming the clinical importance of his work.

Request for Evidence (RFE)

Successfully Addressed

The RFE was issued specifically for the EB1A petition; the legal team responded with additional evidence of the petitioner's stature and the applicability of his research, leading to approval.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions

Similar Cases

Research Fellow

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Arkansas 145 days 2025-08-08
The petitioner proposes to advance research on drug-induced liver injury (DILI) by developing a comprehensive database integrating animal and in vitro study findings. The work focuses on investigating the efficacy of replacing animal testing with in vitro models to predict DILI risks, aiming to accelerate safer and more cost-effective drug development processes.
View Case

Postdoctoral Researcher

Biotechnology · Nigeria

WeGreened EB-2 (NIW) approved
7 days 2024-03-21
The petitioner proposes to conduct translational research focused on identifying molecular targets with therapeutic potential to develop effective treatments for liver cancer and other cancer types characterized by dysregulation. Her work utilizes in silico modeling and direct pharmacological tests of candidate compounds to address the global burden of liver cancer.
View Case

Others

Healthcare · India

WeGreened EB-2 (NIW) approved
Iowa 320 days 2025-03-26
The petitioner proposes to continue research into gastrointestinal and liver diseases, focusing on improving diagnosis, management, and treatment. His work utilizes behavioral and therapeutic strategies to address both the primary diseases and the chronic pain associated with long-term hepatic conditions.
View Case

Research Scientist

Research and Development · Sri Lanka

WeGreened EB-2 (NIW) approved
Minnesota 25 days 2025-03-11
The petitioner proposes to continue her research on improving clinical outcomes for patients with intrahepatic cholangiocarcinoma and other aggressive forms of liver cancer. Her work focuses on unveiling new molecular mechanisms and developing targeted virotherapies through both in vitro and in vivo studies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-06-05.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 49 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist